Saturday, December 28, 2013

Comment Regarding Office Use under DQSA: 503A v. 503B--Are State Boards of Pharmacy Paying Attention!

1 comment:

Kenneth Woliner, MD said...
So, as I read this, any physician (or hospital) who wants to obtain compounded medications for "office use" (i.e. - no patient-specific prescription before the drug is ordered) - needs to buy it from an OUTSOURCING FACILITY. No if's and's or but's.

I hope state boards of medicine and boards of pharmacy are listening.

Kenneth Woliner, MD
www.holisticfamilymed.com

-------
Q: Under the new law, does a pharmacy wishing to compound a sterile non-patient specific product have to register under 503B?
A: Exact quote from Jane Axelrad:
“Section 503A was not changed by the new law and patient specific prescriptions are required under Section 503A. As you know, as you observe, 503B provides a pathway in which hospitals and health care professionals can purchase compounded drugs without prescriptions.”
Q: Only under 503B can you provide non-patient specific product?
A: Exact quote from Jane Axelrad: “If you want to qualify for the exemption under 503A.”

No comments: